Biochemical and virological response of chronic hepatitis C after treatment with interferon-α for 6 or 12 months: Predictors of sustained remission

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 5, 1996, Pages 469-475

  Papatheodoridis, George V ^a   Katsoulidou, Antigoni ^b   Touloumi, Giota ^b   Delladetsima, Johanna K ^c   Hatzakis, Angelos ^b   Tassopoulos, Nicolaos C ^a  

^a Western Attica General Hospital   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Biochemical response; Chronic hepatitis C; HCV genotype; HCV RNA; Interferon ; Virological response

Indexed keywords

ANTIVIRUS AGENT; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; FEMALE; GENOTYPE; GREECE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CHRONIC DISEASE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PROGNOSIS; RNA, VIRAL; TIME FACTORS;

EID: 0029954770     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Davis GL, Balart LA, Schiff ER, Lindsay C, Bodenheimer HC Jr, Perrillo PR, et al.: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter, randomized, controlled trial. N Engl J Med 1989, 321:1501-1506.
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al.: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized double-blind, placebo controlled trial. N Engl J Med 1989, 321:1506-1510.
3. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, et al.: Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis; a multicenter randomized controlled trial from France. Hepatology 1991, 13:393-397.
4. Saracco G, Rosina F, Torrani Cerenzia MR, Lattore V, Chiandussi L, et al.: A randomized controlled trial of interferon alfa-2b as therapy of chronic non-A, non-B hepatitis. J Hepatol 1990, 11 (Supp 1):S43-S49.
5. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ousan D, et al.: Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 1991, 101:497-502.
6. Saez-Royuela F, Porres JC, Moreno A, Castillo I, Martinez G, Galiana F, et al.: High doses of recombinant α-interferon or α-interferon for chronic hepatitis C: a randomized, controlled trial. Hepatology 1991, 13:327-331.
7. Iino S, Hino K, Kuroki T, Suzuki H, Yamamoto S: Treatment of chronic hepatitis C with high-dose interferon α-2b. A multicenter study. Dig Dis Sci 1993, 38:612-618.
8. Metreau JM and the French Croup for the Study of NANB/C Chronic Hepatitis Treatment: Results of a long-term interferon treatment in non-A, non-B/C chronic active hepatitis. Gut 1993, 34 (suppl. 2):S112-S113.
9. Davis GL: Predictors of response to interferon treatment of chronic hepatitis C. J Hepatol 1994, 21:1-3.
10. Kanai K, Iwata K, Nakao K, Kako M, Okamoto H: Suppression of hepatitis C virus RNA by interferon alpha. Lancet 1990, 336:245.
11. Lau JYN, Davis CL, Kniffen J, Qian K-P, Urdea MS, Chan CS, et al.: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993, 341:1501-1504.
12. Shindo M, Di Bisceglie AM, Cheung L, Shih W-K, Cristiano K, Feinstone SM, et al.: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991, 115:700-704.
13. Tsubota A, Chayama K, Ikeda K, Yasuji A, Kaida I, Saitoh S, et al.. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994, 19:1088-1094.
14. Young KKY, Resnick RM, Myers TW: Detection of hepatitis C virus by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993, 31:882-886.
15. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al.: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993, 74:1093-1102.
16. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, et al: Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 1994, 75:1053-1061.
17. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19:1513-1520.
18. Castilla A, Camps-Bansell J, Civeira M-P, Prieto J: Lymphoblastoid α-interferon for chronic hepatitis C: a randomized controlled study. Am J Gastroenterol 1993, 88:233-239.
19. Diodati G, Bonetti P, Noventa F, Casarin C, Rugge M, Scaccabarozzi S, et al.: Treatment of chronic hepatitis C with recombinant human interferon-α 2a: results of a randomized controlled clinical trial. Hepatology 1994, 19:1-5.
20. Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, et al: Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 1995, 21:291-297.
21. Brouwer JT, Nevens F, Cleter GEM, Elewaut A, Adler M, Brenard R, et al.: Treatment of chronic hepatitis C: efficacy of interferon dose and analysis of factors predictive of response. Interim report of 350 patients treated in a Benelux multicentre study [abstract]. Hepatology 1993, 18:110A.
22. Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, et al.: Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 1991, 13:1040-1043.
23. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, et al.: Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 1992, 15:37-41.
24. Lau JYN, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL: Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. Lancet 1993, 342:1208-1209.
25. Reichard O, Glaumann H, Fryden A, Norkrans C, Schvarcz R, Sonnerborg A, et al.: Two-year biochemical, virological and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 1995, 21:918-922.
26. Kanai K, Kako M, Okamoto H: HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992, 339:1543.
27. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al.: Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992, 16:293-299.
28. Okada S-I, Akahane Y, Suzuki H, Okamoto H, Mishiro S: The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992, 16:619-624.
29. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, et al.: Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci 1994, 39:977-982.
30. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Takehara T, Oshita M, et al.: Pretreatment viral load and response to prolonged interferon-α course for chronic hepatitis C. J Hepatol 1995, 22:457-463.
31. 2b for 60 weeks. Hepatology 1994, 19:280-285.
32. Lin R, Roach E, Zimmerman M, Strasser S, Farrell CC: Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. J Hepatol 1995 23:487-496.
33. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, et al.: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995, 332:1457-1462.
34. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, et al.: A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994, 107:812-817.